$7.36−0.20 (−2.65%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD
Olema Oncology (OLMA) Institutional Ownership
13F filers reported holding 59.9% of Olema Oncology (OLMA) shares as of Sep 30, 2026, across 143 filers.
Sources Ownership filingsQuarter ended How we compute thisNot investment advice
- Held by 13F filers
- 59.9%
- Sep 30, 2026
- 13F filers
- 143
- quarter ended Sep 30, 2026
- 13F value
- $453.4M
- 52.5M shares
- Quarter's fund flow
- Mild accumulation
- 22 new · 17 closed
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
13F fund flowQuarter ended Sep 30, 2026*: more funds added or entered than trimmed or exited, mild accumulation (22 new · 54 increased · 27 reduced · 17 closed · 23 unchanged or with no prior quarter on file). Flows at this scale move slowly; treat as context. These positions are 48 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
Basis: shares reported by 143 13F filers for Sep 30, 2026, over shares outstanding implied from the current quote, measured 48 days apart. It measures the ownership we have filings for, not total institutional ownership, and it moves with the share count between filings.
Insider trades · latest filings (Form 4)routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | O'Byrne Jason | CHIEF FINANCIAL OFFICER | Acquired · Grant / award | 650,000Stock Option (Right to Buy) | — | ↗ |
| Jul 24, 2026 | Harmon Cyrus | director | Disposed · Open-market sale | 12,500 | $11.71 | ↗ |
| Jul 23, 2026 | Harmon Cyrus | director | Disposed · Open-market sale | 12,500 | $11.58 | ↗ |
| Jun 18, 2026 | BVF PARTNERS L P/IL | director | Acquired · Grant / award | 29,500Stock Option (Right to buy) | — | ↗ |
| Jun 18, 2026 | Harmon Cyrus | director | Acquired · Grant / award | 29,500Stock Option (Right to Buy) | — | ↗ |
| Jun 18, 2026 | BUTITTA CYNTHIA M | director | Acquired · Grant / award | 29,500Stock Option (right to buy) | — | ↗ |
| Jun 18, 2026 | Garland J. Scott | director | Acquired · Grant / award | 29,500Stock Option (right to buy) | — | ↗ |
| Jun 18, 2026 | Hrustanovic Gorjan | director | Acquired · Grant / award | 29,500Stock Option (right to buy) | — | ↗ |
| Jun 18, 2026 | CLARK IAN T | director | Acquired · Grant / award | 29,500Stock Option (right to buy) | — | ↗ |
| Jun 18, 2026 | Larson Yi | director | Acquired · Grant / award | 29,500Stock Option (right to buy) | — | ↗ |
| Jun 18, 2026 | Horning Sandra | director | Acquired · Grant / award | 29,500Stock Option (right to buy) | — | ↗ |
| Jun 18, 2026 | Raman Prakash | director | Acquired · Grant / award | 29,500Stock Option (right to buy) | — | ↗ |
| Jun 18, 2026 | RAPPAPORT ANDREW | director | Acquired · Grant / award | 29,500Stock Option (right to buy) | — | ↗ |
| Jun 18, 2026 | Graham G. Walmsley | director | Acquired · Grant / award | 29,500Stock Option (right to buy) | — | ↗ |
| Apr 28, 2026 | Raman Prakash | director | Acquired · Grant / award | 2,911Stock Option (Right to Buy) | — | ↗ |
| Apr 28, 2026 | Raman Prakash | director | Acquired · Grant / award | 24,150Stock Option (Right to Buy) | — | ↗ |
| Mar 4, 2026 | Mitchell Shawnte | CHIEF LEGAL OFFICER | Acquired · Option exercise | 25,000 | $4.37 | ↗ |
| Mar 4, 2026 | Mitchell Shawnte | CHIEF LEGAL OFFICER | Disposed · Open-market sale | 24,767 | $24.25 | ↗ |
| Mar 4, 2026 | Mitchell Shawnte | CHIEF LEGAL OFFICER | Disposed · Open-market sale | 233Comon Stock | $24.69 | ↗ |
| Mar 4, 2026 | Mitchell Shawnte | CHIEF LEGAL OFFICER | Disposed · Option exercise | 25,000Stock Option (Right to Buy) | — | ↗ |
* Holdings as reported for Sep 30, 2026, 48 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How much of Olema Oncology do institutions hold?
13F filers reported holding 59.9% of Olema Oncology's shares as of Sep 30, 2026, across 143 filers.
How many 13F filers hold Olema Oncology?
Olema Oncology was held by 143 13F filers as of Sep 30, 2026.
Not investment advice.

